Company: RNST
Filing Date: 2025-02-26
Form Type: PRE 14A
Source: 0000715072-25-000057
Chunk: 52

Company: RENASANT CORP
Filing Date: 2025-02-26
Form: PRE 14A
Chunk 52
---
 |
| Net impact from capital stock offering(3)                  |     |                                                    |   |  0.12 |     |       |   |
| 2024 Adjusted EPS (non-GAAP)                               |     |                                                    | $ |  2.91 |     |       |   |
|                                                            |     | Percentage of Target Performance after adjustment: |   |       |     | 112.4 | % |

(1) Includes the gain on sale, interest earned on the investment of sale proceeds, and the loss of budgeted earnings for the period following the sale of the insurance agency’s business.

(2) Includes merger and conversion related expenses associated with both the sale of the insurance agency and the pending merger with FBMS.

(3) Includes the impact from the increase in diluted shares outstanding and interest earned on the investment of offering proceeds.

<div align='center'>40</div>

| Efficiency Ratio                                           |     |                                                    |     |       |   |     |       |   |
| 2024 Actual efficiency ratio (GAAP)                        |     |                                                    |     | 63.57 | % |     |       |   |
| Adjustments related to the sale of the insurance agency(1) |     |                                                    |     |  5.20 |   |     |       |   |
| Merger and conversion related expenses(2)                  |     |                                                    |     | -1.86 |   |     |       |   |
| Interest earned on the investment of offering proceeds     |     |                                                    |     |  0.40 |   |     |       |   |
| 2024 Adjusted efficiency ratio (non-GAAP)                  |     |                                                    |     | 67.31 | % |     |       |   |
|                                                            |     | Percentage of Target Performance after adjustment: |     |       |   |     | 100.4 | % |

(1) Includes the gain on sale, interest earned on the investment of sale proceeds, and the loss of budgeted earnings for the period following the sale of the insurance agency’s business.

(2) Includes merger and conversion related expenses associated with both the sale of the insurance agency and the pending merger with FBMS.

| Return on Average Tangible Common Equity (ROTCE)           |     |                                                    |     |       |   |     |       |   |
| 2024 Actual ROTCE (non-GAAP)                               |     |                                                    |     |